About Index Trending news
Analyze
Pricing
Fulgent Diagnostics

Fulgent Diagnostics

Work at Fulgent Diagnostics? Add yourself to this profile

Fulgent Diagnostics

A pharmaceutical and next generation molecular diagnostics company focusing on developing and commercializing cancer therapeutics and companion diagnostics.
Edit Profile
More info

Elsewhere

Companies in the same industry

Sirenas Marine Discovery Sirenas Marine Discovery TCD Pharma TCD Pharma Provia Laboratories Provia Laboratories eXIthera Pharmaceuticals eXIthera Pharmaceuticals DelMar Pharma DelMar Pharma SyntheX SyntheX GigaGen GigaGen Symbiomix Symbiomix Arsia Therapeutics Arsia Therapeutics Codiak Biosciences Codiak Biosciences

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
24 May 2016
$27,160,000
Venture capital

SEC FORM D

sec
14 Apr 2016
$5,400,000
Venture capital

SEC FORM D

sec